Search Tag: Michael Porter

ICU Management

2020 29 Sep

Michael Porter, Ph.D., has joined the board of directors of ExThera Medical Corporation, a privately held medical technology company focused on the therapeutic reduction of drug-resistant pathogens and sepsis mediators in whole blood. ExThera’s  Seraph® 100 Microbind® Affinity Blood Filter  (Seraph 100) has a CE Mark in Europe for the treatment...Read more

Executive Health Management

2020 05 Nov

NEW DATE DUE TO COVID-19:  5TH NOVEMBER Find VBHC on Social Media Read more

Executive Health Management

2018 26 Apr

Find VBHC Prize on Social Media        Read more